Australia markets closed

Entourage Health Corp. (ETRGF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.0114+0.0016 (+16.33%)
At close: 09:48AM EDT
Full screen
Trade prices are not sourced from all markets
Previous close0.0098
Open0.0114
Bid0.0000 x 0
Ask0.0000 x 0
Day's range0.0114 - 0.0114
52-week range0.0021 - 0.0210
Volume207
Avg. volume26,378
Market cap3.516M
Beta (5Y monthly)0.97
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • GlobeNewswire

    Entourage Health to Hold First Quarter 2024 Financial Results Call on May 28

    Financial filings are expected after the market closes on May 27, and a management conference call will follow the next dayTORONTO, May 14, 2024 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V:ENTG) (OTCQX: ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning cannabis products announced today it will file its first quarter 2024 financial statements and management’s discussion and analysis after market close on Monday, May 27, 2024. Entourage wil

  • GlobeNewswire

    Entourage Health Introduces New Product Launches and Expands Market Reach of Leading Brand Dime Bag®

    Entourage Unveils Exciting New Product Offerings Diversifying the Company’s Signature BrandsDime Bag® Widens Reach: Popular Offerings Now Across Alberta TORONTO, May 08, 2024 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE:4WE) ("Entourage" or the "Company"), an established Canadian producer and distributor of award-winning cannabis products, today unveiled the expansion of its product portfolio. Entourage also announced the expansion of Dime Bag-branded pre-rolls in

  • GlobeNewswire

    Entourage Health Reports Fiscal Year 2023 Financial Results and Posts $54 Million in Total Revenues

    Strategic Cost Management Signals Stronger Financial Health and Future StabilityGross profit before fair value changes reached $2.4 million, reflecting a 126% year-over-year increase.Company demonstrates financial gains with a 23% reduction in the cost of goods sold.SG&A declined 14% compared to the previous year.Color Cannabis secures a #6 spot in the national pre-roll market. TORONTO, April 30, 2024 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE: 4WE) ("Entourage"